, a risk factor of cardiovascular diseases in spite of their beneficial effects on insulin sensitivity and fat mass.
As for all other NRs, the RXR ligand binding domain folds into a three-layered -helical sandwich defining a hydrophobic ligand-binding pocket (LBP). In the unliganded state, the AF-2 AD (helix 12) is exposed to the solvent and yields free access of the ligand to the LBP (Figure 1 ). The RXR LBP is defined by the amino termini of helices 3 and 9, the two beta sheets, helix 8, the H8-H9 loop, and the carboxyl terminus of helix 11 11 . In analogy with RARs, the synthesis of RXR isotype-specific ligands would have been highly desirable. Unfortunately, the strong conservation of LBD and of LBP (ca. 500
3 ) between RXR isotypes does not allow an easy design of isotype-selective ligands. However, the design of heterodimer-selective rexinoids [12] [13] [14] demonstrated that activation of permissive heterodimers through RXR is a viable option for the pharmacological and possibly therapeutical control of dysregulated cellular pathways 15 . Furthermore, the control of RXR heterodimer non-permissivity through the activation of kinase signaling pathways (desubordination)
provides another tool to modulate RXR heterodimers transcriptional activity 16 . In this review, we will discuss RXR biology and highlight recent advances in this field to forecast how this increased knowledge may create new options for drug discovery.
RXR isotypes: similar but different.
Tissue-specific distribution. The Rxra, Rxrb and Rxrg genes are differently expressed in mouse tissues: Rxra is the major isotype in mouse liver, whereas Rxrb expression is highest in the central nervous system. Rxrg displays a more restricted expression territory, with detectable levels in skeletal muscle and regions of the CNS such as the olfactory bulb and the pituitary glands 17 .
. A third isoform, initially termed hRXRβ3, contains a SLSR sequence inserted in the ligand-binding domain through the use of an alternative 3'-splice acceptor site, similar to the mouse RXRβ2E isoform 20 . This insertion impacts negatively on the ligand binding activity of RXRβ and on its transactivation potential. Finally, mRXRγ1
is strongly expressed in the brain and muscle, whereas the mRXRγ2 isoform has a unique 5'-untranslated region and is expressed highly in both cardiac and skeletal muscles 21 .
The respective role(s) of RXR isotypes and isoforms is not fully understood. Germ line mutations in the Rxr genes induce either in utero lethality through congenital heart defects (RXRα), or metabolic and behavioral defects [RXRβ, RXRγ, reviewed in 22 ]
. From a developmental point of view, RXRα seems to be the main player since mice expressing only RXRα from one allele are viable, indicating a strong functional redundancy 23 . Tissue-specific inactivation of Rxra in hepatocytes [24] [25] [26] [27] [28] or epithelia 29, 30 induces strong phenotypes, indicating a major role of RXRα in these tissues, whereas
Rxra gene knockout has only a mild effect in hematopoietic progenitors 31 . . Finally, Rxrg1 expression is down-regulated in pituitary cells by 9-cis-RA through an atypical DR1 response element 36 .
In contrast, a number of reports documented the proteasomal degradation of RXRα in various cellular backgrounds 37 , which appeared to be conditioned by RXR interaction with RAR and the corepressor SMRT 38, 39 and increased upon agonist binding 40, 41 . Moreover, RXRα breakdown is dependent on MAPK or PKC activity 42, 43 , hinting at a link between RXRα phosphorylation and proteasomal-mediated degradation 44 . . Interestingly, this 44kDa truncated RXR has also been located in the mitochondrial matrix in which it exerts a transcriptional activity 47, 48 , suggesting that RXR can shuttle between the cytoplasmic and nuclear compartments. In line with this, RXRα possess a nuclear localization signal and associates to importin , one of the cellular karyophilins binding the nuclear pore complex. When expressed as a GFP fusion protein, RXRα is mostly located in the nucleus but cytoplasmic RXR provides a piggyback transportation to the vitamin D receptor into the nucleus 49, 50 . The nucleoplasmic sublocalization to the splicing factor compartment may also be another factor controlling RXR transcriptional activities 51 . LPS treatment of target cells can induce both downregulation of Rxr expression and its cytoplasmic relocalization 52 , providing a molecular basis for the observed repression of RXR target genes during TLR4-mediated inflammation. This cytoplasmic relocalization likely depends on RXRα nuclear export signal located in its DBD, which also
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conditions the RXR-mediated targeting of Nur77/NR4A1 and of the thyroid hormone receptor to mitochondria to promote apoptosis 53, 54 . Thus, in addition to a simple, on-off regulatory mechanism of RXR expression, more subtle mechanisms affecting its cellular localization control RXR transcriptional activities and may generate novel functions for this multi-faceted nuclear receptor. Finally, fine-tuning of RXR transcriptional activity also relies on post-translational modifications (PTM): the MAPK-dependent phosphorylation of human RXRα at serine 260 regulates coactivator recruitment to a RXR-VDR dimer 55 and its degradation through the ubiquitin-proteasome pathway 56 , a PTM which can be controlled through the growth factor status of target cells 57 . In addition, RXR phosphorylation on distinct serine residues is dependant on its association with RAR and can affect the transcriptional cooperation between RAR and RXR {Gianni, Tarrade RXR dimerization can also confer new biological properties: as mentioned above, RXR association with Nur77/NR4A1 promotes mitochondrial targeting of Nur77 and subsequent apoptosis 64 , whereas RXR association to the PML-RARα fusion protein unleashes PML-RARα oncogenic
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potential in hematopoietic cells 65, 66 . Of note, a number of proteins involved in various biological processes have been shown to interact physically and/or functionnally with RXRs (Figure 2 . Taken as a whole, these and other data show that RXRs actively contribute to the transcriptional activity of dimers in which they are incorporated, affecting multiple physiological and pathological processes.
Functional redundancy and the lack of specific RXR isotype-specific ligands hinder a detailed investigation of the specific functions, if any, of each RXR isotype. However, a few reports point to distinct functions for each isotype. We recently demonstrated that RXRα/PPARγ heterodimers were much less sensitive to PPARγ agonism than RXRβ/PPARγ heterodimers, due to a strong, ligand-insensitive interaction of the SMRT corepressor with RXRα-containing heterodimers 45 . RXRβ also displays peculiar heterodimerization properties in that it is unable to engage interactions with Nurr1, in contrast to RXRα and RXRγ , although the physiological relevance of such heterodimers has not been definitively established 73 . This call for developmental studies of dimerization-deficient Nurr1 mice. Furthermore, the RXRα and RXRβ subtypes regulate differentially the transcriptional activity of T3R in a chimeric model 74 . In testis, RXRβ expression is confined to Sertoli cells, indicating a critical
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role in spermiation and cholesterol metabolism 75, 76 . Rxrg1 ablation alters the response of cholinergic neurons from the nigrostriatal pathway 77 , in agreement with its expression pattern showing a preferential expression in the brain and skeletal muscle. RXRγ-deficient mice display high metabolic rates and resistance to weight gain when fed a high fat diet, which may stem either from an interference with the thyrotrope axis and/or skeletal muscle-specific effects 78 . These data show that RXR isotypes are involved in a plethora of biological responses which are tissue-and very likely isoform-specific. A more thorough investigation using conditional, tissue-specific KO mice would undoubtedly bring new insights into this complex RXR biology.
RXR permissivity and metabolic regulations
Although highly dependent on the model system used to assess this property, RXR-containing heterodimers can be categorized, quite schematically, as either Apermissive@ or Anon-permissive@, as they can be activated, or not, through the RXR moiety. Nuclear receptors with a high affinity for their cognate ligands are mostly found in the non-permissive category, such as RARs, T3R and VDR . The mechanism by which this molecular crosstalk takes place is still poorly defined, and is very certainly specific for each heterodimer: indeed, while the C-terminal activating function 2 (AF2, required for coactivator recruitment) of RXR is dispensable for PPARγ synergistic activation, it is required for PPAR and T3R activation 81, 82 . The exact physical basis for this functional synergy is unknown, however, mutagenesis studies and structural studies suggest that one coactivator molecule is recruited per heterodimer, with a single LXXLL motif being anchored to each partner 83 . Intriguingly enough, the structural studies dismissed the possibility of allosteric phenomenons between heterodimeric partners, at least for RAR-RXR heterodimers 84 . In contrast, mutagenesis studies of the RXR-LXR complex spoke in favor of allosteric interactions between the two components of the dimer 85 , a difference which could explain the permissive nature of the LXR-RXR dimer. Importantly, the activation of a given permissive
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heterodimer through RXR does not equate activation through the RXR partner: the transcriptional response elicited through RXR overlaps only partially with that elicited through its partner [86] [87] [88] . In a detailed study, it was found that activation of LXR target genes in liver by a rexinoid was restricted to genes involved in lipogenesis, whereas those involved in cholesterol homeostasis were left unaffected.
While providing a molecular explanation for the hypertriglyceridemic effect of bexarotene and possibly other rexinoids, these data raise the yet unresolved question of whether this reflects a selective permissivity of RXR-LXR heterodimer or another mechanism 89 . This may relate to the differential affinity of LXR and RXR for LXXLL-containing peptides 90 and thus to the assembly of distinct coactivator complexes on each receptor monomer. Alternatively, selective post-translational modifications may control RXR permissivity in a promoter-specific context, in analogy to the protein kinase A-dependent desubordination of RXR in the RXR-RAR heterodimer 16 .
Towards heterodimer-specific rexinoids
RXRs can bind a variety of natural and synthetic derivatives, ranging from ω-3 unsaturated fatty acids, the non steroidal anti-inflammatory drug sulindac to organotins 46, 91 . A number of RXR agonists with no isotype selectivity have been synthesized, and much like for other NRs, the concept of selective nuclear receptor modulator (SNuRM) applies to this class of compounds. Indeed, the structural diversity of rexinoids translates into distinct patterns of gene expression induced upon treatment of target cells by these molecules 92 , as described previously for other NRs 93 . For example, the two rexinoids HX630 and LG268 induce only partially overlapping gene expression profiles when used in combination with a RAR agonist, Am580
88
. Furthermore, LG268 is a rather promiscuous rexinoid, since able to activate both RXR-LXR and RXR-PPARγ dimers, whereas HX630
induces a preferential activation of RXR-PPARγ dimers 94 . Along the same line, the poorly active rexinoid HX600 acts as an efficient activator of RXRα-and RXRγ -Nur77/NR4A1 dimers, but not of RXRβ-Nur77 dimers, the latter feature being in line with the reported inability of RXRβ to dimerize with Nurr1/NR4A2 95 . Interestingly, the rexinoid LG101506 activates selectively RXR-PPARγ heterodimers, but not RXR-RAR or RXR-LXR heterodimers 15 . In agreement with the predicted biological consequences of PPARγ activation, this compound lowered significantly blood glucose levels in genetically diabetic mice and did not increase blood triglyceride levels in Sprague-Dawley rats
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after a seven day treatment 96 . However, RXR antagonism in the RXR-PPARγ dimer has also proven to be efficient in normalizing glycemia and fat mass in animal models 97 , but this pharmacological option has not been explored further. Taken together, these data suggest that the design of heterodimer-specific rexinoids can be envisioned, although no precise rules have emerged yet for an efficient drug design.
The RXR cistrome
The recent availability of deep sequencing techniques led to the identification of RXR dimer DNA binding sites on a genome-wide scale. A consistent finding was that these potential regulatory sites are very often located at intronic locations at a distance from the transcriptional start site of regulated genes, calling for the re-examination of previous promoter studies which identified functional response elements in the vicinity of promoter regions. Another observation was that a vast majority of these heterodimer binding sites are prebound by RXR and that either ligand treatment or increased expression of the RXR partner lead to the expected heterodimer formation. This suggests a model in which RXR serves as a docking site for multiple nuclear receptors, and that the heterodimer composition will vary according to extra-or intracellular cues activating or repressing RXR and/or its dimerization partner. Furthermore, these data provide a general ground for the widely held assumption that RXR increases the DNA binding affinity of RXR-containing heterodimers [98] [99] [100] .
Concluding remarks
Heterodimerization is a general, simple mechanism by which a linear signaling pathway can be converted into a very complex network acting in a cell-specific manner in response to physiological or pathological cues. RXRs act as common heterodimerization partners for a number of other nuclear receptors, and as such are often considered as loosening the specificity of the signaling pathway. As a consequence, their usefulness as drug targets has been dismissed. However, the occurrence of several isotypes, and of multiple isoforms raise the possibility, as demonstrated by some reports described above, that RXR functions may be diverse and mediated through distinct molecular entities.
An in-depth understanding of their respective biological functions, as well as the identification of 
